Abilify® (aripiprazole) 7.5mg/mL solution for injection (intramuscular) - Revised SPC
Source: eMC (electronic Medicines Compendium) Area: Other Library Updates > SPC Changes Section 4.4 of the SPC has also been updated to include reports from post-marketing data of pathological gambling. Patients with a prior history of pathological gambling may be at increased risk and should be monitored carefully. Section 4.8 of the SPC has also been updated to include the following adverse reactions - psychiatric disorders, agitation, nervousness, pathological gambling, suicide attempt, suicidal ideation and completed suicide. Please see SPC link for full prescribing information.